Transcription of PROXY PAPER TEVA PHARMACEUTICAL …
{{id}} {{{paragraph}}}
PROXY PAPERTEVA PHARMACEUTICAL INDUSTRIES Stock Exchange: teva ISIN: IL0006290147 MEETING DATE:13 JULY 2017 RECORD DATE:13 JUNE 2017 PUBLISH DATE:27 JUNE 2017 COMPANY DESCRIPTION teva PHARMACEUTICAL Industries Limited develops,manufactures, markets, and distributes genericmedicines and a portfolio of specialty medicinesworldwide. It operates through two segments, GenericMedicines and Specialty MEMBERSHIP:TA-25; TA-100 SECTOR:HEALTHCAREINDUSTRY: PHARMACEUTICAL SCOUNTRY OF TRADE:ISRAELCOUNTRY OF INCORPORATION:UNITED STATESVOTING IMPEDIMENT:NONE DISCLOSURES:NONE OWNERSHIPESG PROFILEPREVIOUS BOARDVOTE RESULTSAPPENDIX2017 ANNUAL MEETING PROPOSALISSUEBOARDGLASS Election of Directors Elect Sol J. Barer Elect Jean-Michel Halfon Elect Murray A. Goldberg Elect Nechemia Peres Elect Roberto A. Mignone Elect Perry Nisen Compensation Terms of Chair Employment Terms of Interim President and CEO Directors' Fees Amendment to the 2015 Long-Term Equity-BasedIncentive Plan 2017 Executive Incentive Compensation Plan Reduction of Authorized Shares Appointment of Auditor FORFORSHARE OWNERSHIP PROFILESHARE BREAKDOWN 1 SHARE CLASSADR-EACH CNV INTO 1 , MVOTES PER SHARE1 INSIDE OWNERS** CA
share ownership profile share breakdown 1 share class adr-each cnv into 1 ord ils0.10 shares outstanding 1,016.0 m votes per share 1 inside ownership 0.00%
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}